Drug Discovery Featured Articles & Applications

1. Research Center Layout Helps Lower Barriers To Cross-Industry Collaboration 3/27/2026

   Discover how one research center, uniquely built for collaboration, enables the collection and analysis of high-quality specimens and data that will fuel both current and future research collaborations.

2. What If The U.S. Government Stopped Funding Biotech? 3/23/2026

   It sets off a real tension – ideological, economic, even personal. But what would happen if the U.S. government cut direct financial support for “biotechnology research,” leaving it entirely to investors, private and public markets, and bigger pharma? "Our industry’s mind-meld says with no government largesse our biotech industry collapses," writes Chief Editor Louis Garguilo. It's an "outlandish hypothetical," but he asks for a few minutes to go through this. And he has help in making his case.

3. What's Next For ADCs: How Combinations Will Help Define The Future Of Treatment 3/23/2026

   Insights gained from advancing ADC combination therapies in lung cancer are now shaping innovative approaches across multiple tumor types.

4. 5 Takeaways From The Boston Open Science & Innovation Forum 3/20/2026

   The recent Boston Open Science & Innovation Forum was co-hosted by the Open Molecular Software Foundation (OMSF) and Ginkgo Datapoints.

5. From "Live Drug" To Precision Tool: Redefining CAR T Safety 3/20/2026

   Through important chemistry and the right engineering, there’s new opportunity for CAR T therapeutics to target different forms of cancer with limited toxicity.

6. NAMs In France And Europe: The Current Landscape 3/20/2026

   The EU is establishing a credible and scalable NAM ecosystem, but challenges still need to be overcome before life sciences professionals and patients can reap the benefits.

7. Rethinking Tau Biology: The Future Of Neurodegenerative Drug Discovery 3/19/2026

   We caught up with Melissa Murray, Ph.D., and Amy Rommel, Ph.D., to discuss tau-associated neurodegenerative diseases.

8. Proteomics Biomarkers Beyond Blood 3/16/2026

   Effective biomarker strategies have the potential to accelerate decision-making, de-risk development, and help drive precision medicine.

9. MicroRNA Therapeutics In Metabolic Liver Disease: Context-Driven Drug Discovery 3/12/2026

   Realizing the therapeutic potential of miRNAs in liver disease requires confronting a problem the field has not fully reckoned with.

10. Viral Coinfections: Emerging Challenges In Modern Drug Discovery 3/11/2026

    Viral coinfection is a phenomenon more complex than just the concurrency or sequential infection with multiple viruses in the same host.